Nearctic \u3ci\u3eAcleris\u3c/i\u3e: Resurrection of \u3ci\u3eA. Stadiana\u3c/i\u3e and a Revised Identity for \u3ci\u3eA. Semiannula\u3c/i\u3e (Lepidoptera: Tortricidae)

Type study showed that Acleris stadiana (Barnes & Busck), currently considered a junior synonym of A. semiannula (Robinson), is in fact a distinct taxon. Although superficially similar, these taxa differ markedly in genital structure. In males of A. semiannula, the aedeagus is short, broad, and virtually straight, whereas in those of A. stadiana, it is long, thin, and sharply bent. What was known in literature as A. semiannula proved to be A. stadi­ana. We redefine both A. semiannula and the resurrected A. stadiana

The influence of a mean magnetic field on three-dimensional magnetohydrodynamic turbulence

Building on results from two-dimensional magnetohydrodynamic (MHD) turbulence (Shebalin, Matthaeus & Montgomery 1983), the development of anisotropic states from initially isotropic ones is investigated numerically for fully three-dimensional incompressible MHD turbulence. It is found that when an external d.c. magnetic field (B₀) is imposed on viscous and resistive MHD systems, excitations are preferentially transferred to modes with wavevectors perpendicular to B₀). The anisotropy increases with increasing mechanical and magnetic Reynolds numbers, and also with increasing wavenumber. The tendency of B₀ to inhibit development of turbulence is also examined

Errors and Discrepancies in Measurement of Tooth Size

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66948/2/10.1177_00220345600390022301.pd

Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy

Objectives.This study of hypertensive left ventricular hypertrophy 1) assessed myocardial shortening in both the circumferential and long-axis planes, and 2) investigated the relation between geometry and systolic function.Background.In hypertensive left ventricular hypertrophy, whole-heart studies have suggested normal systolic function on the basis of ejection fraction-systolic stress relations. By contrast, isolated muscle data show that contractility is depressed. It occurred to us that this discrepancy could be related to geometric factors (relative wall thickness).Methods.We studied 43 patients with hypertensive left ventricular hypertrophy and normal ejection fraction (mean ± SD 69 ± 13%) and 50 clinically normal subjects. By echocardiography, percent myocardial shortening was measured in two orthogonal planes; circumferential shortening was measured at the endocardium and at the midwall, and long-axis shortening was derived from mitral annular motion (apical four-chamber view). Circumferential shortening was related to end-systolic circumferential stress and long-axis shortening to meridional stress.Results.Endocardial circumferential shortening was higher than normal (42 ± 10% vs. 37 ± 5%, p < 0.01) and midwall circumferential shortening lower than normal in the left ventricular hypertrophy group (18 ± 3% vs. 21 ± 3%, p < 0.01). Differences between endocardial and midwall circumferential shortening are directly related to differences in relative wall thickness. Long-axis shortening was also depressed in the left ventricular hypertrophy group (18 ± 6% in the left ventricular hypertrophy group, 21 ± 5% in control subjects, p < 0.05). Midwall circumferential shortening and end-systolic circumferential stress relations in the normal group showed the expected inverse relation; those for ∼33% of the left ventricular hypertrophy group were >2 SD of normal relations, indicating depressed myocardial function. There was no significant relation between long-axis shortening and meridional stress, indicating that factors other than afterload influence shortening in this plane.Conclusions.High relative wall thickness allows preserved ejection fraction and normal circumferential shortening at the endocardium despite depressed myocardial shortening in two orthogonal planes

A study of the effect of lenses and prisms on vertical ductions at 16 inches

A study of the effect of lenses and prisms on vertical ductions at 16 inche

Efficacy of direct‐acting antivirals: UK real‐world data from a well‐characterised predominantly cirrhotic HCV cohort

Direct‐acting antivirals (DAAs) have revolutionised the management of chronic hepatitis C virus (HCV) infection. We describe UK real‐world DAA experience. Individuals commencing HCV treatment containing a DAA regimen (Mar 2014‐Nov 2016), participating in the National HCV Research UK (HCVRUK) Cohort Study were recruited from 33 UK HCV centers. The data were prospectively entered at sites onto a centralised database. The data were reported as median (Q1‐Q3). Of the 1448 treated patients, 1054 (73%) were males, the median age being 54 years (47‐60), 900 (62%) being genotype 1 and 455 (31%) genotype 3. The majority, 887 (61%) had cirrhosis, and 590 (41%) were treatment‐experienced. DAA regimens utilised: genotype1 sofosbuvir (SOF)/Ledipasvir/±Ribavirin (625/900, 69%) and Ombitasvir/Paritaprevir/Dasabuvir/±RBV (220/900, 24%), and in genotype 3 SOF/Daclatasvir + RBV (256/455, 56%) and SOF/pegylated interferon/RBV (157/455, 35%). Overall, 1321 (91%) achieved sustained virological response (SVR12), genotype 1 vs 3, 93% vs 87%, P < .001. Prior treatment, presence of cirrhosis and treatment regimen did not impact SVR12. Predictors of treatment failure were genotype 3 infection, OR, 2.015 (95% CI: 1.279‐3.176, P = .003), and male sex, OR, 1.878 (95% CI: 1.071‐3.291, P = .028). Of those with hepatic decompensation at baseline (n = 39), 51% (n = 20) recompensated post‐treatment, lower baseline serum creatinine being associated with recompensation (P = .029). There were two liver‐related deaths, both having decompensated disease. This real‐world UK data, comprising of a predominantly cirrhotic HCV genotype 1/3 cohort, confirms DAA efficacy with an overall 91% SVR12, with 51% recompensating post‐treatment. Genotype 3 infection was a predictor of treatment failure

DICER1 gene mutations in endocrine tumors

In this review, the importance of theDICER1gene in the function of endocrine cells is discussed. There is conclusive evidence thatDICER1mutations play a crucial role in the development, progression, cell proliferation, therapeutic responsiveness and behavior of several endocrine tumors. We review the literature ofDICER1gene mutations in thyroid, parathyroid, pituitary, pineal gland, endocrine pancreas, paragangliomas, medullary, adrenocortical, ovarian and testicular tumors. Although significant progress has been made during the last few years, much more work is needed to fully understand the significance ofDICER1mutations.</jats:p